Ingredion (INGR) Q3 2026 Earnings Call Transcript
Ingredion (INGR) reported Q3 2026 earnings below expectations, with net sales up 2% excluding the Pakistan business sale. Higher manufacturing costs and a stronger Mexican peso pressured profitability. The company lowered its full-year outlook due to slower-than-expected profit recovery at Argo and cautious consumer demand views. Texture & Healthful Solutions saw 2% net sales volume growth, while Food & Industrial Ingredients LATAM grew 4%.
How this was made

The 30-second read
Why it matters
The earnings miss and guidance cut suggest near-term downside risk, but long-term growth from clean label solutions and the Tate & Lyle deal may provide upside.
Market read
Earnings miss and lowered guidance are likely to depress INGR stock, while the acquisition progress may influence sector peers.
What to watch
New capacity additions and clean label growth could offset short-term profit pressure.
Background
Ingredion reported Q3 2026 results, missing expectations and lowering its full-year outlook while discussing cost pressures and the ongoing Tate & Lyle acquisition.
Ticker impact
Q3 2026 earnings call disclosed lower full-year outlook and higher costs, impacting profitability.
likely downward pressure as market prices in weaker outlook
Earnings miss and lowered guidance are fresh material that typically trigger sell pressure.
Market effects
Food ingredients sector may face margin pressure from higher input costs.
Latin America operations see currency headwinds; U.S./Canada volumes decline.
Tate & Lyle acquisition progress may affect broader specialty ingredients market.
Counterpoint
If cost controls improve faster than expected, the stock could rebound on margin recovery.
Key entities
- CompanyIngredion
Food ingredients producer reporting Q3 2026 earnings.
- CompanyTate & Lyle
Target of pending acquisition by Ingredion.


